Targeted drugs are a cornerstone of personalized medicine, yet come with important drawbacks. They restrain disease progression -- but rarely eradicate the cancer. Patients therefore need to take the drugs essentially forever, exposing them to severe side effects and incurring high costs for the healthcare system. Combination therapies could potentially overcome these limitations. A new study shows how epigenetic analysis and automated microscopy help prioritize new drug combinations for leukemia therapy.
from Top Health News -- ScienceDaily http://bit.ly/2HANDcJ
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
Employee sentenced for stealing more than $400K from San Diego corporation
from Yahoo News - Latest News & Headlines https://ift.tt/0rXscSg
-
from Yahoo News - Latest News & Headlines https://ift.tt/m2VMCS1
-
from Yahoo News - Latest News & Headlines https://ift.tt/jYPuwNf
-
from Yahoo News - Latest News & Headlines https://ift.tt/Ot2Ebrh
No comments:
Post a Comment